Madison startup developing drugs based on bones, teeth has new WARF license
169659
post-template-default,single,single-post,postid-169659,single-format-standard,bridge-core-1.0.5,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

Madison startup developing drugs based on bones, teeth has new WARF license

Madison startup developing drugs based on bones, teeth has new WARF license

Dianomi Therapeutics, 504 S. Rosa Road, is part of the Forward BIO Initiative, a collaboration of UW-Madison, the state's economic development organization and the biohealth industry.  STEVE APPS, STATE JOURNAL ARCHIVES

Dianomi Therapeutics is part of the Forward BIO Initiative, a collaboration of UW-Madison, the state’s economic development organization and the biohealth industry. Steve Apps, State Journal Archives

Located in University Research Park, Dianomi is developing pain medications and other drugs using mineral coated microparticles, which mimic properties in bones and teeth, to make drugs last longer and work more effectively.

The technology stems from research by Bill Murphy, a UW-Madison biomedical engineer who is the company’s co-founder and chief scientific officer. It is based in part on archaeological studies that showed proteins in fossils could remain stable for centuries if associated with calcium-based minerals.

Dianomi’s lead product is a biologic drug for osteoarthritis of the knee, and the company has also worked on a corticosteroid.

READ MORE